Eurofarma Laboratórios
Brazil - São Paulo
BiotechnologyFocus: Small Molecules, Generics
Error: Unreachable/Blocked
ImmunologyOphthalmologyCardiovascular
Open Jobs
0
Products & Portfolio (8)
2 discontinued products not shown
BETAXOLOL HYDROCHLORIDE
betaxolol hydrochloride
Post-LOE
OPHTHALMIC · SOLUTION/DROPS
HCl, a cardioselective (beta-1-adrenergic) receptor inhibitor, does not have significant membrane-stabilizing (local anesthetic) activity and is devoid of intrinsic sympathomimetic action. Orally administered beta-adrenergic receptor inhibitors reduce cardiac output in healthy subjects and patients with heart disease. In patients with severe impairment of myocardial function, beta-adrenergic receptor antagonists may inhibit the sympathetic stimulatory effect necessary to maintain adequate cardiac function. When instilled in the eye, BETOPTIC S has the action of reducing elevated IOP, whether or not accompanied by glaucoma. Ophthalmic betaxolol has minimal effect on pulmonary and cardiovascular parameters. Elevated IOP presents a major risk factor in glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss. Betaxolol has the action of reducing elevated as well as normal IOP and the mechanism of ocular hypotensive action appears to be a reduction of aqueous production as demonstrated by tonography and aqueous fluorophotometry.
elevated intraocular pressure (IOP) in patients with chronic open-angle glaucomaocular hypertensionhypertension+1 more
2001
30
LOPROX
ciclopirox
LOE Approaching
TOPICAL · CREAM
1982
30
LOPROX
ciclopirox
LOE Approaching
TOPICAL · SUSPENSION
1988
30
NEO-SYNALAR
neomycin sulfate and fluocinolone acetonide
Post-LOE
TOPICAL · CREAM
Corticosteroid Hormone Receptor Agonists
1963
30
SYNALAR
fluocinolone acetonide
LOE Approaching
TOPICAL · CREAM
Corticosteroid Hormone Receptor Agonists
1963
30
SYNALAR
fluocinolone acetonide
LOE Approaching
TOPICAL · SOLUTION
1964
30
SYNALAR
fluocinolone acetonide
LOE Approaching
TOPICAL · OINTMENT
Corticosteroid Hormone Receptor Agonists
1963
30
VANCOMYCIN HYDROCHLORIDE
vancomycin hydrochloride
Post-LOE
INJECTION · INJECTABLE
2008
30
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 10 approved products
Top TAs: Immunology, Cardiovascular, Ophthalmology
Portfolio Health
LOE Approaching6 (60%)
Post-LOE4 (40%)
10 total products
Therapeutic Area Focus
Marketed
Pipeline